Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium for Methotrexate-Induced Spermatotoxicity
NCT06951282Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- May 2024
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Phase 2, open-label trial (4 arms), sponsored by Ain Shams University. Primary endpoints: Seminal glutathione peroxidase level at 3 months, Semen volume at 3 months and 4 more. Started May 2024; status: completed.
Beyond the preview
Go deeper on NCT06951282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06951282.